Literature DB >> 33693039

Association of N-Terminal Pro-brain Natriuretic Peptide With Volume Status and Cardiac Function in Hemodialysis Patients.

Yaqiong Wang1,2,3,4,5, Xuesen Cao1,2,3,4,5, Jinbo Yu1,2,3,4,5, Yongmei Zhang1,2,3,4,5, Xianzhe Li1,2,3,4,5, Xiaohong Chen1,2,3,4,5, Jianzhou Zou1,2,3,4,5, Bo Shen1,2,3,4,5, Xiaoqiang Ding1,2,3,4,5.   

Abstract

Introduction: N-terminal-pro-brain natriuretic peptide (NT-pro BNP) is secreted by cardiomyocytes in cases of cardiac structure disorder and volume overload. However, the relationship between NT-pro BNP level and body fluid status in dialysis patients with reduced cardiac ejection function (EF) is uncertain. Therefore, we aimed to investigate this relationship.
Methods: We enrolled patients who had been receiving hemodialysis for >3 months. Blood sample, transthoracic echocardiographic, and bioimpedance spectroscopy measurements were performed during a midweek non-dialysis day. The predictive value of NT-pro BNP in hemodialysis patients with volume overload was analyzed.
Results: A total of 129 hemodialysis patients (74 men and 55 women; mean age: 59.4 ± 13.0 years) were recruited. The average hemodialysis duration was 55.5 (23.9-93.4) months, the NT-pro BNP level was 4992 (2,033-15,807) pg/mL, and the value of overhydration was 2.68 ± 0.19 (-1.9 to 12.2) L. The NT-pro BNP level was independently correlated with overhydration in both the LVEF ≥ 60% (β = 0.236, P = 0.044) and LVEF <60% (β = 0.516, P = 0.032) groups, even after adjustments for potentially confounding variables. In receiver operating characteristic curves of NT-pro BNP for predicting volume overload, the area under the curve was 0.783 [95% CI (0.688-0.879), P < 0.001) and 0.788 [95% CI (0.586-0.989), P < 0.001] in the LVEF ≥ 60% and LVEF < 60% groups, respectively. Conclusions: NT-pro BNP is a predictive factor for volume overload in hemodialysis patients with or without EF declines.
Copyright © 2021 Wang, Cao, Yu, Zhang, Li, Chen, Zou, Shen and Ding.

Entities:  

Keywords:  N-terminal pro-brain natriuretic peptide; body composition monitor; ejection fraction; hemodialysis; volume overload

Year:  2021        PMID: 33693039      PMCID: PMC7937607          DOI: 10.3389/fcvm.2021.646402

Source DB:  PubMed          Journal:  Front Cardiovasc Med        ISSN: 2297-055X


  3 in total

1.  Benefits of BNP/NT-proBNP serum level evaluation for dry weight adjustment in pediatric hemodialysis patients.

Authors:  Antoine Mouche; Cyrielle Parmentier; Fatma Fendri; Claire Herbez-Rea; Anne Couderc; Laurène Dehoux; Marina Avramescu; Theresa Kwon; Julien Hogan; Jean-Daniel Delbet; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2022-06-27       Impact factor: 3.714

2.  Prediction of Heart Function and Volume Status in End-Stage Kidney Disease Patients through N-Terminal Pro-Brain Natriuretic Peptide.

Authors:  Kyung Ho Lee; Inki Moon; Young Seung Oh; Byung Chul Yu; Moo Yong Park; Jin Kuk Kim; Soo Jeong Choi
Journal:  Medicina (Kaunas)       Date:  2022-07-22       Impact factor: 2.948

3.  Multifrequency bioimpedance by spectroscopy vs. routine methods in the management of hydration status in peritoneal dialysis patients: A randomized control trial.

Authors:  Fabiana Lourenço Costa; Nayrana Soares do Carmo Reis; Fabricio Moreira Reis; Rogério Carvalho de Oliveira; Silméia Garcia Zanati Bazan; Maryanne Zilli Canedo da Silva; Luis Cuadrado Martin; Pasqual Barretti
Journal:  Front Med (Lausanne)       Date:  2022-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.